Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator
- PMID: 30354651
- DOI: 10.1161/CIRCULATIONAHA.118.033505
Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator
Abstract
Background: Coronary artery calcium (CAC) is a powerful novel risk indicator for atherosclerotic cardiovascular disease (ASCVD). Currently, there is no available ASCVD risk prediction tool that integrates traditional risk factors and CAC.
Methods: To develop a CAC ASCVD risk tool for younger individuals in the general population, subjects aged 40 to 65 without prior cardiovascular disease from 3 population-based cohorts were included. Cox proportional hazards models were developed incorporating age, sex, systolic blood pressure, total and high-density lipoprotein cholesterol, smoking, diabetes mellitus, hypertension treatment, family history of myocardial infarction, high-sensitivity C-reactive protein, and CAC scores (Astro-CHARM model [Astronaut Cardiovascular Health and Risk Modification]) as dependent variables and ASCVD (nonfatal/fatal myocardial infarction or stroke) as the outcome. Model performance was assessed internally, and validated externally in a fourth cohort.
Results: The derivation study comprised 7382 individuals with a mean age 51 years, 45% women, and 55% nonwhite. The median CAC was 0 (25th, 75th [0,9]), and 304 ASCVD events occurred in a median 10.9 years of follow-up. The c-statistic was 0.784 for the risk factor model, and 0.817 for Astro-CHARM ( P<0.0001). In comparison with the risk factor model, the Astro-CHARM model resulted in integrated discrimination improvement (0.0252), and net reclassification improvement (0.121; P<0.0001), as well. The Astro-CHARM model demonstrated good discrimination (c=0.78) and calibration (Nam-D'Agostino χ2, 13.2; P=0.16) in the validation cohort (n=2057; 55 events). A mobile application and web-based tool were developed to facilitate clinical application of this tool ( www.AstroCHARM.org ).
Conclusion: The Astro-CHARM tool is the first integrated ASCVD risk calculator to incorporate risk factors, including high-sensitivity C-reactive protein and family history, and CAC data. It improves risk prediction in comparison with traditional risk factor equations and could be useful in risk-based decision making for cardiovascular disease prevention in the middle-aged general population.
Keywords: calcification of joints and arteries; coronary vessels; risk assessment.
Comment in
-
In middle-aged adults, Astro-CHARM was better than a standard risk factor model for predicting 10-year ASCVD risk.Ann Intern Med. 2019 Feb 19;170(4):JC23. doi: 10.7326/ACPJ201902190-023. Ann Intern Med. 2019. PMID: 30776812 No abstract available.
Similar articles
-
Coronary Artery Calcium Scores and Atherosclerotic Cardiovascular Disease Risk Stratification in Smokers.JACC Cardiovasc Imaging. 2019 May;12(5):852-861. doi: 10.1016/j.jcmg.2017.12.017. Epub 2018 Feb 14. JACC Cardiovasc Imaging. 2019. PMID: 29454784 Free PMC article.
-
Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.J Am Coll Cardiol. 2016 May 31;67(21):2480-7. doi: 10.1016/j.jacc.2016.03.538. J Am Coll Cardiol. 2016. PMID: 27230043 Free PMC article.
-
Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment.J Am Coll Cardiol. 2016 Jan 19;67(2):139-147. doi: 10.1016/j.jacc.2015.10.058. J Am Coll Cardiol. 2016. PMID: 26791059 Free PMC article.
-
Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: A Systematic Evidence Report for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. Report No.: 17-05225-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. Report No.: 17-05225-EF-1. PMID: 30234933 Free Books & Documents. Review.
-
Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2018 Jul 17;320(3):281-297. doi: 10.1001/jama.2018.4242. JAMA. 2018. PMID: 29998301 Review.
Cited by
-
Cardiovascular Care of Tactical Athletes: Have We Landed Yet?JACC Adv. 2024 Aug 30;3(10):101236. doi: 10.1016/j.jacadv.2024.101236. eCollection 2024 Oct. JACC Adv. 2024. PMID: 39280796 Free PMC article. No abstract available.
-
Longitudinal evaluation of manufacturer-specific differences for high-sensitive CRP EQA results.Front Mol Biosci. 2024 Aug 8;11:1401405. doi: 10.3389/fmolb.2024.1401405. eCollection 2024. Front Mol Biosci. 2024. PMID: 39176390 Free PMC article.
-
Comparison of Coronary Artery Calcium and Quantitative Coronary Plaque in Predicting Obstructive Coronary Artery Disease: Subgroup Analysis of the CLARIFY Study.Heart Int. 2024 Mar 28;18(1):44-50. doi: 10.17925/HI.2024.18.1.7. eCollection 2024. Heart Int. 2024. PMID: 39006468 Free PMC article.
-
Considering clonal hematopoiesis of indeterminate potential in space radiation risk analysis for hematologic cancers and cardiovascular disease.Commun Med (Lond). 2024 Jun 11;4(1):105. doi: 10.1038/s43856-023-00408-4. Commun Med (Lond). 2024. PMID: 38862635 Free PMC article.
-
[C-reactive protein, cardiovascular issues of an acute-phase protein: an update for theclinician].Arch Cardiol Mex. 2024 Feb 2;94(2):191-202. doi: 10.24875/ACM.23000032. Arch Cardiol Mex. 2024. PMID: 38306406 Free PMC article. Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials